# Impax Laboratories, LLC

Impax Laboratories, LLC is a company headquartered in Hayward, CA, United States.

## Company overview

- **Legal name:** Impax Laboratories, LLC
- **Former names in filing history:** IMPAX LABORATORIES INC (2000-05-04 to 2018-05-04); GLOBAL PHARMACEUTICAL CORP \DE\ (1996-10-29 to 1999-12-27)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Hayward, CA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001003642

## About

Impax Laboratories, LLC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001003642, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2018-03-01, it reported annual revenue of USD 775,787,000; net income of USD -469,287,000; total assets of USD 1,351,300,000 for the fiscal period ended 2017-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2017 (period ended 2017-12-31)

- **Revenue:** $775.8M (USD 775,787,000)
- **Net income:** -$469.3M (USD -469,287,000)
- **Total assets:** $1.4B (USD 1,351,300,000)
- **Cash and equivalents:** $181.8M (USD 181,778,000)
- **Operating cash flow:** $84.2M (USD 84,222,000)

### FY2016 (period ended 2016-12-31)

- **Revenue:** $824.4M (USD 824,429,000)
- **Total assets:** $1.8B (USD 1,823,018,000)
- **Cash and equivalents:** $180.1M (USD 180,133,000)
- **Operating cash flow:** $74.6M (USD 74,597,000)
- **Later filings:** Operating cash flow: shown as originally filed; later filings report different values for the same periods.

### FY2015 (period ended 2015-12-31)

- **Revenue:** $860.5M (USD 860,469,000)
- **Net income:** $39.0M (USD 38,997,000)
- **Total assets:** $1.9B (USD 1,922,487,000)
- **Cash and equivalents:** $340.4M (USD 340,351,000)

### FY2014 (period ended 2014-12-31)

- **Revenue:** $596.0M (USD 596,049,000)
- **Net income:** $57.4M (USD 57,353,000)
- **Total assets:** $1.1B (USD 1,079,197,000)
- **Cash and equivalents:** $214.9M (USD 214,873,000)
- **Operating cash flow:** $32.8M (USD 32,817,000)

## Recent SEC filings

- Form 10-Q — filed 2018-05-10 — period 2018-03-31 — 10-Q
- Form 8-K — filed 2018-05-07 — period 2018-05-07 — 8-K
- Form 8-K — filed 2018-04-30 — period 2018-04-30 — 8-K
- Form 10-K/A — filed 2018-04-13 — period 2017-12-31 — 10-K/A
- Form 8-K — filed 2018-03-27 — period 2018-03-27 — 8-K
- Form 8-K — filed 2018-03-20 — period 2018-03-19
- Form 8-K — filed 2018-03-19 — period 2018-03-19 — 8-K
- Form 8-K — filed 2018-03-07 — period 2018-03-07 — 8-K
- Form 8-K — filed 2018-03-05 — period 2018-03-02 — 8-K
- Form 10-K — filed 2018-03-01 — period 2017-12-31 — 10-K
- Form 8-K — filed 2018-03-01 — period 2018-03-01 — 8-K
- Form SC 13G — filed 2018-02-12 — SCHEDULE 13G

---

Updated: 2026-10-23T20:10:52Z

Canonical page: https://altss.com/profile/impax-laboratories-llc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology